Ian Matthew White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ian Matthew White has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- David J. Boegner
Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA
6 shared publications Wei W. Yu
Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742 USA
6 shared publications- Don DeVoe
Department of Mechanical Engineering, University of Maryland, College Park, USA
4 shared publications Imaly A. Nanayakkara
Fischell Department of Bioengineering , University of Maryland , 8278 Paint Branch Drive , College Park , Maryland 20742 , United States
4 shared publicationsSoroush H. Yazdi
Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA
4 shared publicationsStephen M. Restaino
Maryland Development Center, United States
4 shared publications
Latest Publications
- Open Access
- 21 July 2026
- Published by MDPI AG in Biosensors
- Vol. 16  (7) , 393
Sample-to-Answer Point-of-Care Blood Lead Level Test
Children who are exposed to lead may have extensive health problems, in particular intelligence deficits and developmental delays. Wide-reaching screening programs are essential to identify children in need of remediation and medical intervention. Lead exposure is most problematic in low- and middle-income countries, as well as in underserved populations in wealthier regions of the world. To increase accessibility, it is critical that screening tools are inexpensive, portable, and easy to use. Here we report a low-cost, handheld, sample-to-answer system for the detection of lead in whole blood samples. Our assay simultaneously lyses blood cells, liberates lead from hemoglobin, aggregates proteins and cellular debris, and separates the solubilized lead from the aggregate via a simple filtration device. Using a screen-printed carbon electrode, anodic stripping voltammetry with a low-cost potentiostat, and our sample-to-answer workflow, we achieved a limit of detection of 1.44 ÎĽg/dL, which is below the blood lead reference value established by the US Centers for Disease Control and Prevention (3.5 ÎĽg/dL). We validated our system using pre-quantified reference samples from lead-exposed animals and demonstrated excellent agreement with our calibration curve, including for samples near the 3.5 ÎĽg/dL threshold.
- 21 July 2026
- Published by MDPI AG in Biosensors
- Vol. 16  (7) , 393
Open AccessSample-to-Answer Point-of-Care Blood Lead Level Test
Children who are exposed to lead may have extensive health problems, in particular intelligence deficits and developmental delays. Wide-reaching screening programs are essential to identify children in need of remediation and medical intervention. Lead exposure is most problematic in low- and middle-income countries, as well as in underserved populations in wealthier regions of the world. To increase accessibility, it is critical that screening tools are inexpensive, portable, and easy to use. Here we report a low-cost, handheld, sample-to-answer system for the detection of lead in whole blood samples. Our assay simultaneously lyses blood cells, liberates lead from hemoglobin, aggregates proteins and cellular debris, and separates the solubilized lead from the aggregate via a simple filtration device. Using a screen-printed carbon electrode, anodic stripping voltammetry with a low-cost potentiostat, and our sample-to-answer workflow, we achieved a limit of detection of 1.44 ÎĽg/dL, which is below the blood lead reference value established by the US Centers for Disease Control and Prevention (3.5 ÎĽg/dL). We validated our system using pre-quantified reference samples from lead-exposed animals and demonstrated excellent agreement with our calibration curve, including for samples near the 3.5 ÎĽg/dL threshold.
- 29 January 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98  (5) , 3951-3958
Automated Enrichment of DNA Biomarkers from Large-Volume Samples: Detection of B. burgdorferi Cell-Free DNA in Urine
Liquid biopsies enable rapid and noninvasive analysis for disease biomarkers. However, in the early stages of a disease, biomarkers are often present in extremely dilute concentrations, making them difficult to isolate and quantify. We have developed an Automated Magnetically and Thermally Induced Conical Separator (Auto-MATICS), which enables purification and enrichment of trace biomarkers from large volume biological samples (up to 15 mL) using magnetic beads and thermally responsive alkane partitions (TRAPs). Here, we quantify the enrichment capabilities of the Auto-MATICS and demonstrate a diagnostic application by detecting fragmented genomic DNA from Borrelia burgdorferi (the bacteria that causes Lyme disease) in 15 mL synthetic urine samples. We achieved detection of approximately 0.1 copies/ÎĽL of fragmented DNA, nearly 200X better than in a perfectly clean but unenriched sample. We expect that the Auto-MATICS platform can have significant impact on a broad range of diagnostics applications in which trace biomarkers must be detected from large-volume complex biological matrices.
- 29 January 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98  (5) , 3951-3958
Automated Enrichment of DNA Biomarkers from Large-Volume Samples: Detection of B. burgdorferi Cell-Free DNA in Urine
Liquid biopsies enable rapid and noninvasive analysis for disease biomarkers. However, in the early stages of a disease, biomarkers are often present in extremely dilute concentrations, making them difficult to isolate and quantify. We have developed an Automated Magnetically and Thermally Induced Conical Separator (Auto-MATICS), which enables purification and enrichment of trace biomarkers from large volume biological samples (up to 15 mL) using magnetic beads and thermally responsive alkane partitions (TRAPs). Here, we quantify the enrichment capabilities of the Auto-MATICS and demonstrate a diagnostic application by detecting fragmented genomic DNA from Borrelia burgdorferi (the bacteria that causes Lyme disease) in 15 mL synthetic urine samples. We achieved detection of approximately 0.1 copies/ÎĽL of fragmented DNA, nearly 200X better than in a perfectly clean but unenriched sample. We expect that the Auto-MATICS platform can have significant impact on a broad range of diagnostics applications in which trace biomarkers must be detected from large-volume complex biological matrices.
- Open Access
- 13 January 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26  (4) , 897-905
Poly(lactic- co -glycolic acid) for reagent storage and controlled release in thermoplastic microfluidics
On-chip reagent storage and controlled release is demonstrated using poly(lactic- co -glycolic acid) (PLGA) as a polymer-based approach to reagent integration within thermoplastic microfluidic chips for nucleic acid amplification testing.
- 13 January 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26  (4) , 897-905
Open AccessPoly(lactic- co -glycolic acid) for reagent storage and controlled release in thermoplastic microfluidics
On-chip reagent storage and controlled release is demonstrated using poly(lactic- co -glycolic acid) (PLGA) as a polymer-based approach to reagent integration within thermoplastic microfluidic chips for nucleic acid amplification testing.
- 27 September 2025
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 447  (Pt 2)
Portable histone assay technology (PHAST) for the sample-to-answer detection of circulating histones in whole blood
- 27 September 2025
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 447  (Pt 2)
Portable histone assay technology (PHAST) for the sample-to-answer detection of circulating histones in whole blood
- Open Access
- 29 April 2025
- Published by MDPI AG in Biosensors
- Vol. 15  (5) , 276
Thermally Responsive Alkane Partitions and a Magnetofluidic Assay for Point-of-Sample Detection of Viruses in Wastewater
Detecting, identifying, and tracking genetic material in wastewater allows public health agencies to accurately monitor the spread of infectious diseases in communities. In response to the COVID-19 pandemic, viral diagnostics for wastewater have been used to track the spread of SARS-CoV-2 and other viruses and have allowed public health officials to make more informed decisions regarding public safety. However, due to the cost and complexity of viral RNA/DNA detection platforms, analysis is limited to sophisticated laboratory facilities, which limits deployment and delays results. In contrast, a low-cost rapid point-of-sample solution for the detection of viruses in wastewater would enable worldwide deployment with immediate analytical results. We have recently reported the development of thermally responsive alkane partitions (TRAPs) for automated magnetofluidic assays, enabling sample-to-answer point-of-care detection of viruses in complex samples. Here we demonstrate the use of TRAPs in combination with hydrogel-coated magnetic particles for virus purification and assay automation to enable detection of SARS-CoV-2 from spiked wastewater samples in a low-cost cassette within a handheld instrument. Using this system, we show distinguishable detection of SARS-CoV-2 below 200 copies/mL in wastewater.
- 29 April 2025
- Published by MDPI AG in Biosensors
- Vol. 15  (5) , 276
Open AccessThermally Responsive Alkane Partitions and a Magnetofluidic Assay for Point-of-Sample Detection of Viruses in Wastewater
Detecting, identifying, and tracking genetic material in wastewater allows public health agencies to accurately monitor the spread of infectious diseases in communities. In response to the COVID-19 pandemic, viral diagnostics for wastewater have been used to track the spread of SARS-CoV-2 and other viruses and have allowed public health officials to make more informed decisions regarding public safety. However, due to the cost and complexity of viral RNA/DNA detection platforms, analysis is limited to sophisticated laboratory facilities, which limits deployment and delays results. In contrast, a low-cost rapid point-of-sample solution for the detection of viruses in wastewater would enable worldwide deployment with immediate analytical results. We have recently reported the development of thermally responsive alkane partitions (TRAPs) for automated magnetofluidic assays, enabling sample-to-answer point-of-care detection of viruses in complex samples. Here we demonstrate the use of TRAPs in combination with hydrogel-coated magnetic particles for virus purification and assay automation to enable detection of SARS-CoV-2 from spiked wastewater samples in a low-cost cassette within a handheld instrument. Using this system, we show distinguishable detection of SARS-CoV-2 below 200 copies/mL in wastewater.
- 14 December 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 271, 117052
Sample-to-answer detection of miRNA from whole blood using thermally responsive alkane partitions
- 14 December 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 271, 117052
Sample-to-answer detection of miRNA from whole blood using thermally responsive alkane partitions
- 24 August 2024
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 421
Saliva-STAT: Sample-to-answer saliva test for COVID-19
- 24 August 2024
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 421
Saliva-STAT: Sample-to-answer saliva test for COVID-19
- 8 July 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96  (29) , 12049-12056
Sample-to-Answer Detection of SARS-CoV-2 Viremia Using Thermally Responsive Alkane Partitions
The diagnosis of bloodborne viral infections (viremia) is currently relegated to central laboratories because of the complex procedures required to detect viruses in blood samples. The development of point-of-care diagnostics for viremia would enable patients to receive a diagnosis and begin treatment immediately instead of waiting days for results. Point-of-care systems for viremia have been limited by the challenges of integrating multiple precise steps into a fully automated (i.e., sample-to-answer), compact, low-cost system. We recently reported the development of thermally responsive alkane partitions (TRAPs), which enable the complete automation of diagnostic assays with complex samples. Here we report the use of TRAPs for the sample-to-answer detection of viruses in blood using a low-cost portable device and easily manufacturable cassettes. Specifically, we demonstrate the detection of SARS-CoV-2 in spiked blood samples, and we show that our system detects viremia in COVID-19 patient samples with good agreement to conventional RT-qPCR. We anticipate that our sample-to-answer system can be used to rapidly diagnose SARS-CoV-2 viremia at the point of care, leading to better health outcomes for patients with severe COVID-19 disease, and that our system can be applied to the diagnosis of other life-threatening bloodborne viral diseases, including Hepatitis C and HIV.
- 8 July 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96  (29) , 12049-12056
Sample-to-Answer Detection of SARS-CoV-2 Viremia Using Thermally Responsive Alkane Partitions
The diagnosis of bloodborne viral infections (viremia) is currently relegated to central laboratories because of the complex procedures required to detect viruses in blood samples. The development of point-of-care diagnostics for viremia would enable patients to receive a diagnosis and begin treatment immediately instead of waiting days for results. Point-of-care systems for viremia have been limited by the challenges of integrating multiple precise steps into a fully automated (i.e., sample-to-answer), compact, low-cost system. We recently reported the development of thermally responsive alkane partitions (TRAPs), which enable the complete automation of diagnostic assays with complex samples. Here we report the use of TRAPs for the sample-to-answer detection of viruses in blood using a low-cost portable device and easily manufacturable cassettes. Specifically, we demonstrate the detection of SARS-CoV-2 in spiked blood samples, and we show that our system detects viremia in COVID-19 patient samples with good agreement to conventional RT-qPCR. We anticipate that our sample-to-answer system can be used to rapidly diagnose SARS-CoV-2 viremia at the point of care, leading to better health outcomes for patients with severe COVID-19 disease, and that our system can be applied to the diagnosis of other life-threatening bloodborne viral diseases, including Hepatitis C and HIV.
- Open Access
- 17 November 2022
- Published by MDPI AG in Biosensors
- Vol. 12  (11) , 1030
Sample-to-Answer Immuno-Magnetic Assay Using Thermally Responsive Alkane Partitions
To combat pandemics, there is a need for rapid point-of-care diagnostics to identify infected patients and to track the spread of the disease. While recent progress has been made in response to COVID-19, there continues to be a need for point-of-care diagnostics capable of detecting biomarkers—such as antibodies—in whole blood. We have recently reported the development of thermally responsive alkane partitions (TRAPs) for the automation of point-of-care immuno-magnetic assays. Here, we demonstrate the use of TRAPs to enable sample-to-answer detection of antibodies against the SARS-CoV-2 virus in whole blood samples. We report a limit of detection of 84 pg/mL, well below the clinically relevant threshold. We anticipate that the TRAP-enabled sample-to-answer immunoassay can be used to track the progression of future pandemics, leading to a more informed and robust clinical and societal response.
- 17 November 2022
- Published by MDPI AG in Biosensors
- Vol. 12  (11) , 1030
Open AccessSample-to-Answer Immuno-Magnetic Assay Using Thermally Responsive Alkane Partitions
To combat pandemics, there is a need for rapid point-of-care diagnostics to identify infected patients and to track the spread of the disease. While recent progress has been made in response to COVID-19, there continues to be a need for point-of-care diagnostics capable of detecting biomarkers—such as antibodies—in whole blood. We have recently reported the development of thermally responsive alkane partitions (TRAPs) for the automation of point-of-care immuno-magnetic assays. Here, we demonstrate the use of TRAPs to enable sample-to-answer detection of antibodies against the SARS-CoV-2 virus in whole blood samples. We report a limit of detection of 84 pg/mL, well below the clinically relevant threshold. We anticipate that the TRAP-enabled sample-to-answer immunoassay can be used to track the progression of future pandemics, leading to a more informed and robust clinical and societal response.
- Open Access
- 11 February 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14  (7) , 8865-8875
Thermally Responsive Alkane Partitions for Assay Automation
For point-of-care diagnostic tools to be impactful, they must be inexpensive, equipment-free, and sample-to-answer (i.e., require no user intervention). Here, we report a new approach to enable sample-to-answer diagnostics that utilizes thermally responsive alkane partitions (TRAPs) as automated pseudo-valves. When combined with the magnetic manipulation of microbeads, TRAPs enable the pumpless automation of all steps in complex assays. We demonstrate that in relatively narrow channel geometries, liquified alkane partitions continue to separate reagents on each side of the partition while enabling the transition of magnetic beads from one reagent to the next, replacing manual pipetting steps in conventional assays. In addition, we show that in relatively broader geometries, liquified partitions breach, enabling the addition/mixing of preloaded reagents. Through calculation and experimentation, we determine the geometric design rules for implementing the stationary and removable partitions in fluidic channels. In addition, we demonstrate that magnetic microbeads can be pulled through liquified stationary TRAPs without disrupting partition integrity and without disrupting bound protein complexes attached at the microbead surface. The TRAP technology introduced here can enable a new low-cost and equipment-free approach for fully automated sample-to-answer diagnostics.
- 11 February 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14  (7) , 8865-8875
Open AccessThermally Responsive Alkane Partitions for Assay Automation
For point-of-care diagnostic tools to be impactful, they must be inexpensive, equipment-free, and sample-to-answer (i.e., require no user intervention). Here, we report a new approach to enable sample-to-answer diagnostics that utilizes thermally responsive alkane partitions (TRAPs) as automated pseudo-valves. When combined with the magnetic manipulation of microbeads, TRAPs enable the pumpless automation of all steps in complex assays. We demonstrate that in relatively narrow channel geometries, liquified alkane partitions continue to separate reagents on each side of the partition while enabling the transition of magnetic beads from one reagent to the next, replacing manual pipetting steps in conventional assays. In addition, we show that in relatively broader geometries, liquified partitions breach, enabling the addition/mixing of preloaded reagents. Through calculation and experimentation, we determine the geometric design rules for implementing the stationary and removable partitions in fluidic channels. In addition, we demonstrate that magnetic microbeads can be pulled through liquified stationary TRAPs without disrupting partition integrity and without disrupting bound protein complexes attached at the microbead surface. The TRAP technology introduced here can enable a new low-cost and equipment-free approach for fully automated sample-to-answer diagnostics.